ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,698Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 682

$1.54M Total Retail Price of All Prescriptions

Rank: 32 out of 682

821 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 821 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

32% of this provider’s 821 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 25,471 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,472 1,075 S3 1 1
OMEPRAZOLE 1,156 896 2 5
LISINOPRIL 1,156 873 2 2
AMLODIPINE BESYLATE 1,103 953 4 6
FUROSEMIDE 1,073 908 5 7
LEVOTHYROXINE SODIUM 1,011 890 6 3
SIMVASTATIN 797 695 7 4
GABAPENTIN 667 520 8 9
WARFARIN SODIUM 650 524 9 13
METFORMIN HCL 620 448 10 8
POTASSIUM CHLORIDE 613 532 11 14
HYDROCHLOROTHIAZIDE 556 481 12 12
METOPROLOL TARTRATE 443 381 13 10
CITALOPRAM HBR 441 374 14 17
NEXIUM 433 298 15 19
LOSARTAN POTASSIUM 404 369 16 20
CLOPIDOGREL 371 309 17 25
CARVEDILOL 367 315 18 23
LEVOFLOXACIN 363 273 19 70
RANITIDINE HCL 363 303 19 28
ATENOLOL 338 240 21 18
SERTRALINE HCL 332 302 22 24
DONEPEZIL HCL 330 329 23 30
PREDNISONE 320 260 24 40
TAMSULOSIN HCL 313 238 25 33
METOPROLOL SUCCINATE 293 250 26 16
ADVAIR DISKUS 277 239 27 47
CRESTOR 268 206 28 22
PRAVASTATIN SODIUM 257 207 29 15
ATORVASTATIN CALCIUM 250 194 30 11
PLAVIX 236 204 31 35
ISOSORBIDE MONONITRATE ER 235 192 32 31
POLYETHYLENE GLYCOL 3350 226 208 33 44
DIOVAN 222 183 34 42
TRAZODONE HCL 220 185 35 38
SPIRIVA 218 162 36 49
DIGOXIN 216 198 37 46
ZOLPIDEM TARTRATE 209 170 38 21
PAROXETINE HCL 201 152 39 53
NAMENDA 190 176 40 41
RISPERIDONE 184 124 41 82
PROAIR HFA 177 120 42 45
GLIPIZIDE 172 151 43 61
HYDRALAZINE HCL 171 163 44 74
AMIODARONE HCL 171 171 44 170
FAMOTIDINE 170 143 46 99
CEPHALEXIN 169 128 47 128
AMOX TR-POTASSIUM CLAVULANATE 166 138 48 110
TRAMADOL HCL 159 140 49 26
AMITRIPTYLINE HCL 154 91 R 50 50
SYMBICORT 141 110 51 117
COMBIVENT 136 111 52 105
SINGULAIR 131 90 53 63
MIRTAZAPINE 131 116 53 52
JANUVIA 130 112 55 62
CYCLOBENZAPRINE HCL 128 60 R 56 65
FENOFIBRATE 127 110 57 76
EXELON 126 116 58 104
KLOR-CON 8 122 100 59 235
PROMETHAZINE HCL 121 96 R 60 54
FLUOXETINE HCL 121 69 60 60
CIPROFLOXACIN HCL 117 103 62 58
BYSTOLIC 114 107 63 118
VERAPAMIL ER 110 93 64 116
FLUTICASONE PROPIONATE 109 73 65 36
PREMARIN 108 69 R 66 132
GLIPIZIDE ER 102 87 67 108
RAMIPRIL 100 100 68 81
CARBIDOPA-LEVODOPA 99 80 69 121
THEOPHYLLINE ANHYDROUS 98 84 70 153
ALENDRONATE SODIUM 98 91 70 37
LIPITOR 98 89 70 92
DILTIAZEM ER 97 84 73 136
LOVAZA 97 76 73 106
PANTOPRAZOLE SODIUM 97 85 73 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 76 76 34
MONTELUKAST SODIUM 96 63 76 112
MELOXICAM 94 44 78 27
LEVETIRACETAM 89 63 79 125
NYSTATIN 86 71 80 95
INSULIN SYRINGE 85 52 81 75
ZETIA 85 75 81 69
NOVOLIN R 83 62 83 167
BACLOFEN 81 53 84 130
DILTIAZEM 24HR CD 79 67 85 123
LOSARTAN-HYDROCHLOROTHIAZIDE 78 67 86 56
QUETIAPINE FUMARATE 78 52 86 87
DETROL LA 77 68 88 226
GLIPIZIDE XL 76 71 89 181
ROPINIROLE HCL 76 73 89 71
LEVEMIR 75 35 91 185
BUSPIRONE HCL 75 63 91 102
TRICOR 75 64 91 94
AGGRENOX 75 75 91 255
LANTUS 73 51 95 55
GLYBURIDE 72 68 R 96 72
VYTORIN 72 53 96 145
IBUPROFEN 72 67 96 79
ENALAPRIL MALEATE 70 58 99 91
VESICARE 70 47 99 240
NAPROXEN 69 56 101 97
DOXEPIN HCL 67 43 102 205
METHOCARBAMOL 66 37 R 103 163
DIVALPROEX SODIUM ER 65 16 104 221
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 50 105 103
ALLOPURINOL 61 56 106 32
AZITHROMYCIN 61 45 106 39
DIVALPROEX SODIUM 60 37 108 84
ALPRAZOLAM 60 53 108 90
CEFPROZIL 56 47 110 260
NITROSTAT 56 41 110 161
VENTOLIN HFA 56 36 110 101
EVISTA 56 56 110 135
NASONEX 56 39 110 199
AMOXICILLIN 56 44 110 113
AVODART 56 56 110 211
CILOSTAZOL 55 51 117 183
EXFORGE 55 47 117 237
TRILIPIX 54 29 119 192
NITROFURANTOIN 53 53 120 233
PRADAXA 53 43 120 231
ACETAMINOPHEN-CODEINE 52 50 S3 122 126
VENLAFAXINE HCL ER 51 19 123 119
TOPIRAMATE 50 0 124 150
CLONIDINE HCL 50 38 124 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.